Clinical trial
Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients…
NCT00300521 · Beijing Chao Yang Hospital, Other · Completed
Key facts
| NCT number | NCT00300521 |
|---|---|
| Title | Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma |
| Official title | Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma |
| Lead sponsor | Beijing Chao Yang Hospital, Other |
| Collaborators | Tongji University The No.180 Hospital of People's Liberation Army |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatocellular Carcinoma, Liver Transplantation |
| Intervention type | Genetic |
| Interventions | ADV-TK (adenovirus-thymidine kinase enzyme) gene therapy |
| Enrollment | 40 |
| Start date | Sep 1, 2000 |
| Completion | Nov 1, 2005 |
| First posted | Mar 9, 2006 |
| Last update posted | Mar 9, 2006 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: